Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03939299
Other study ID # CLARIFY-CTO
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 15, 2019
Est. completion date December 31, 2023

Study information

Verified date May 2019
Source Shanghai Zhongshan Hospital
Contact Hongbo Yang, M.D.
Phone 008613585890793
Email yang.hongbo@zs-hospital.sh.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

True-false-true occurred during wire penetration in coronary CTO procedure. Subintimal stenting influences vascular response. Intravenous ultrasound confirmed wire position in the procedure. Then stenting procedure was performed. Optical coherence tomography was used for exploring long-term vascular response and healing profile after successful coronary stenting in CTO lesions.


Description:

Chronic total occlusions (CTOs) are defined as coronary lesions with thrombolysis in myocardial infarction (TIMI) grade flow of 0 and present for more than 3 months. CTO is commonly recognized as the toughest lesion subset to be treated by percutaneous coronary interventions. With the remarkable progress in the technologies and techniques achieved in the PCI for CTO over the last decade, the rate of procedural success increased to 80-90%. Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts. At present, four strategies were used for CTO lesions, including: ante-grade wire escalation, ante-grade dissection reentry (ADR), retro-grade wire escalation, and retrograde dissection reentry (RDR). True-false-true occurred during wire penetration. Subintimal stenting influences vascular response. Intravenous ultrasound (IVUS) confirmed wire position in the procedure. Then stenting procedure was performed according to standard routine. Optical coherence tomography (OCT) was used for exploring long-term vascular response and healing profile after successful coronary stenting in CTO lesions.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- 18~85 years old;

- Agree percutaneous coronary intervention without related contraindications;

- Chronic total occlusion confirmed by clinical and angiographic data, predicted high successful rate of stent implantation;

- Subjects (or legal guardians) understanding the testing requirements and procedures, and providing written informed consent.

Exclusion Criteria:

- Subjects associated with drugs allergy (such as contrast, sirolimus, or structure-related compounds fluorinated polymers, thienopyridine or aspirin);

- Subjects with active peptic ulcer, active gastrointestinal (GI) bleeding or other bleeding diathesis or coagulopathy;

- Subjects being suffered from other serious illness (such as cancer, congestive heart failure), which may cause drop in life expectancy to less than 12 months;

- Pregnant or breastfeeding women;

- Refused this trial;

- Subjects with severe liver or renal dysfunction (ALT >5×ULN,eGFR< 30ml/min/1.73mm2 or Scr>200 mmol/L);

- Active bleeding;

- Bleeding diathesis or coagulopathy, malignant tumors;

- Contraindication of anticoagulant drugs;

- Subjects with other situation not suitable for the study.

Study Design


Related Conditions & MeSH terms

  • Chronic Total Occlusion of Coronary Artery

Intervention

Procedure:
OCT
Patients with coronary chronic total occlusion received successful stenting. Optimal coherence tomography imaged immediately and at 9-12 months after the index procedure to explore long-term vascular response and healing profile.

Locations

Country Name City State
China Zhongshan Hospital, Fudan University Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Shanghai Zhongshan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary long-term minimal stent area measured through OCT imaging result 9-12 month after index procedure
Primary long-term stent thrombosis measured through OCT imaging result 9-12 month after index procedure
Primary long-term stent neointima measured through OCT imaging result 9-12 month after index procedure
Primary long-term stent malapposition measured through OCT imaging result 9-12 month after index procedure
Primary immediately minimal stent area measured through OCT imaging result in the procedure
Primary immediately stent malapposition measured through OCT imaging result in the procedure
Secondary Major Adverse Cardiovascular Events clinical follow-up record 9-12 month after index procedure
See also
  Status Clinical Trial Phase
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03475888 - Incidence of Ventricular Arrhythmias in Patients With Chronic Total Occlusion Recanalization N/A
Not yet recruiting NCT04917432 - Early and Midterm Outcomes of Intravascular Ultrasound (IVUS) Versus Non-IVUS Guidance in Complex Coronary Chronic Total Occlusion (CTO) Revascularization. N/A
Recruiting NCT04944615 - To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease. N/A
Completed NCT01861860 - OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA N/A
Recruiting NCT05142215 - A Placebo-controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention for the Relief of Stable Angina N/A
Active, not recruiting NCT05464147 - DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions N/A
Recruiting NCT04145167 - Observational Registry on Clinical Outcome After Diagnosis of Chronic Total Occlusions
Not yet recruiting NCT04965207 - EvaLuAtion On the cHaracteristics of the True/False lUmen and Its Prognostic Value for cOronary CTO Patients Just Before Stent Implantation
Active, not recruiting NCT05197361 - Microvascular Coronary Resistance and Absolute Coronary FLOW in Patients With Percutaneous Intervention of a Chronic Total Occlusion
Recruiting NCT05813704 - Coronary Crossing System in Patients With Coronary Chronic Total Occlusions N/A
Recruiting NCT03563417 - ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO N/A
Completed NCT05377866 - Holo CTO Proctoring Study
Completed NCT01978860 - A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter N/A
Withdrawn NCT02784418 - The SHINE-CTO Trial N/A
Completed NCT03988166 - Chronic Total Occlusion Percutaneous Coronary Intervention Study N/A
Completed NCT02477579 - A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions N/A
Completed NCT03209843 - Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO) N/A
Completed NCT03947398 - The BLIMP Balloon in Coronary Interventions N/A
Active, not recruiting NCT04060615 - Properties of Myocardial Microcirculation in Patients With Different Pathomorphological Substrates, Before and After Recanalization of Coronary Artery CTO N/A